Sirolimus versus cyclosporine A in patients with primary acquired pure red cell aplasia: a prospective cohort study

Blood Cancer J. 2023 May 10;13(1):74. doi: 10.1038/s41408-023-00845-3.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cyclosporine* / therapeutic use
  • Humans
  • Prospective Studies
  • Sirolimus* / therapeutic use

Substances

  • Cyclosporine
  • Sirolimus

Associated data

  • ClinicalTrials.gov/NCT04470804